Replies to post #115745 on Biotech Values

[10nisman]

If NVS thinks this than so does MNTA then what would be the impetus for MNTA to reduce its Copaxone share :)

To immediately remove some of the overhang in the current stock price. I was just throwing out the question to see what everyone thought.